We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Esure | LSE:ESUR | London | Ordinary Share | GB00B8KJH563 | ORD 1/12P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 279.60 | 279.40 | 279.80 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/4/2014 13:05 | Yes I certainly do but exactly what is the point you are trying to make here? A prospective dividend of 17.35p for the current year on a buying price of 250p. Work out the equation for yourself and then see what answer you come up with. | masurenguy | |
09/4/2014 12:25 | "Topped up at 250p this morning since the projected yield at this price is almost 7%." Do you know how to use a calculator? | bikeaholic | |
09/4/2014 09:51 | Topped up at 250p this morning since the projected yield at this price is almost 7%. | masurenguy | |
09/4/2014 09:39 | Dividend was 13.3p per share, which is more than covered by the drop today (so far). To be honest, I'm a bit surprised by the hammering this has taken in the last ten trading days. This is a great, profitable company whose shares should be north of £3. I wouldn't be surprised if this experiences a significant bounce within the next month. As Dr Biotech observes, if you bought in at the IPO, to be sitting now at 250p on a 16% loss is pretty galling for a company that has nothing wrong with it. | jbat | |
09/4/2014 09:31 | I've had a quick look around and can't see anything negative at the mo. Have made a small top up. | yam114 | |
09/4/2014 09:12 | Quite a steep drop over the last couple of days even allowing for the xd. Its been a disappointing performance for those who bought in at the IPO. There is some threat of referral for the insurance industry but I don't see this lot being hit particularly. | dr biotech | |
09/4/2014 09:05 | it has gone ex dvd today..15.8p i think the total was by memory to be paid may23 | limit up | |
09/4/2014 09:01 | Anyone know anything re the large drop it looks a bit bonkers to me. May have to top up. | yam114 | |
09/4/2014 08:56 | Yes but not 7%. | bikeaholic | |
31/3/2014 13:40 | The drop is just part of the ongoing lazy uptrend up from the drop late last year. There doesn't need to be a specific reason for it - it's just part of the price action. | jbat | |
31/3/2014 11:48 | Possibly a broker downgrade or the end of the lock in period? Nearly a year since the flotation. | dr biotech | |
31/3/2014 10:42 | Why the drop this morning? Any views? | danboris2 | |
29/3/2014 08:10 | Sending along nicely. Quality management, writing quality business, profitably. | gutterhead | |
14/3/2014 17:20 | Weird price movement!!!!! Who knows something???? Its not automated trading anyway!!!! Decent volume too!!!! | bikeaholic | |
12/3/2014 14:46 | Well, one can only speculate about that at this stage. Unless they have financial setbacks going forward - which can afflict them aswell as anyone else - I can't see them reducing the overall dividend, irrespective of its existing component parts. | masurenguy | |
12/3/2014 13:00 | Mas - thanks. seen those posts. i'm more interested in the composition of the dividend i.e. even if they have a progressive policy on the base dividend, the special dividend element (see above quote from Prelims) appears to be more flexible. So there may be years where the special dividend (which comprises part of the full year dividend) may be reduced or not paid at all if they had a need for the cash. So looking at the full year dividend (base dividend + special dividend) there is perhaps greater risk here that the full year div may go down as opposed as up due to how they calculate it, just as there is with other insurers that have similar core dividends topped annually with special dividends (LRE etc). | speedsgh | |
12/3/2014 10:59 | Posts #353 & 357 | masurenguy | |
12/3/2014 09:54 | "The full year dividend comprises a base dividend of 9.3 pence per share and a special dividend of 6.5 pence per share. The special dividend has been set with reference to the Group's capital resource requirements, prospective premium growth expectations and a prudent margin for contingencies. It is the combination of these factors that the Board has examined when setting the final dividend that we have announced today." Only just started looking here + have not yet seen IPO/any other doc re their dividend policy. However from this statement in the Prelim Results it sounds like the full year dividend will comprise a base dividend topped up by a variable special dividend on an annual basis. This is relatively common among insurers. By my calcs the 2013 base dividend of 9.3p when annualised equates to 11.16p, which at current price gives a base yield of just over 4%. Is this as others understand it? | speedsgh | |
11/3/2014 23:21 | Was there any Jan/Feb 14 storm damage mentioned in the results statement or they saving it for later hence the market reaction... | diku | |
11/3/2014 13:35 | Just a little short term profit taking, with only around 0.5% of shares traded since the open, after a 25% rise over the past 4 months. Solid fundamentals, good yield and great prospects. | masurenguy | |
11/3/2014 13:10 | Must admit I am disappointed with the reaction today. It may be interesting to dig out the forecasts as the IPO and to see how they compare to todays results. I know the big drop last year was when the house broker downgraded the growth. | dr biotech | |
11/3/2014 10:50 | Great results, should steadily climb as lots of headroom whilst still protecting div yield. | gutterhead | |
11/3/2014 10:09 | I agree with you Masurenguy. Got to be one of the highest yields in the 350 which should attract a few | dr biotech |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions